---
title: "12 Health Care Stocks Moving In Tuesday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294120254.md"
description: "During Tuesday's after-market session, several healthcare stocks experienced significant volatility. Gainers included Autonomix Medical (up 49.1%), CalciMedica (up 9.8%), and Catheter Precision (up 8.21%). Conversely, notable losers were NeuroPace (down 15.8%), NextCure (down 12.71%), and rYojbaba (down 12.43%). The report highlights specific price movements and market capitalizations for these companies."
datetime: "2026-07-28T21:06:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294120254.md)
  - [en](https://longbridge.com/en/news/294120254.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294120254.md)
---

# 12 Health Care Stocks Moving In Tuesday's After-Market Session

### Gainers

-   **Autonomix Medical** (NASDAQ:AMIX) stock rose 49.1% to $4.1 during Tuesday's after-market session. The market value of their outstanding shares is at $1.5 million.
-   **CalciMedica** (NASDAQ:CALC) shares rose 9.8% to $0.79. The company's market cap stands at $11.1 million.
-   **Catheter Precision** (AMEX:VTAK) stock moved upwards by 8.21% to $0.3. The company's market cap stands at $1.0 million.
-   **OneMedNet** (NASDAQ:ONMD) stock moved upwards by 7.98% to $0.77. The company's market cap stands at $34.5 million.
-   **Jaguar Health** (NASDAQ:JAGX) shares increased by 7.83% to $1.04. The company's market cap stands at $4.9 million.
-   **Regentis Biomaterials** (AMEX:RGNT) shares moved upwards by 6.74% to $1.9. The market value of their outstanding shares is at $14.4 million.

### Losers

-   **NeuroPace** (NASDAQ:NPCE) stock decreased by 15.8% to $12.89 during Tuesday's after-market session. The company's market cap stands at $521.6 million.
-   **NextCure** (NASDAQ:NXTC) shares declined by 12.71% to $4.73. The market value of their outstanding shares is at $20.8 million.
-   **rYojbaba** (NASDAQ:RYOJ) stock decreased by 12.43% to $4.37. The company's market cap stands at $42.7 million.
-   **Lisata Therapeutics** (NASDAQ:LSTA) shares decreased by 12.07% to $1.02. The market value of their outstanding shares is at $13.1 million.
-   **Scinai Immunotherapeutics** (NASDAQ:SCNI) stock decreased by 8.34% to $0.24. The market value of their outstanding shares is at $1.2 million.
-   **Verrica Pharmaceuticals** (NASDAQ:VRCA) shares declined by 5.56% to $5.1. The market value of their outstanding shares is at $91.9 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [VTAK.US](https://longbridge.com/en/quote/VTAK.US.md)
- [NPCE.US](https://longbridge.com/en/quote/NPCE.US.md)
- [AMIX.US](https://longbridge.com/en/quote/AMIX.US.md)
- [RYOJ.US](https://longbridge.com/en/quote/RYOJ.US.md)
- [NXTC.US](https://longbridge.com/en/quote/NXTC.US.md)
- [CALC.US](https://longbridge.com/en/quote/CALC.US.md)
- [ONMD.US](https://longbridge.com/en/quote/ONMD.US.md)
- [JAGX.US](https://longbridge.com/en/quote/JAGX.US.md)
- [RGNT.US](https://longbridge.com/en/quote/RGNT.US.md)
- [LSTA.US](https://longbridge.com/en/quote/LSTA.US.md)
- [SCNI.US](https://longbridge.com/en/quote/SCNI.US.md)
- [VRCA.US](https://longbridge.com/en/quote/VRCA.US.md)
- [ONMDW.US](https://longbridge.com/en/quote/ONMDW.US.md)

## Related News & Research

- [NeuroPace's Panel Track Supplement Not Approvable in Current Form, FDA Says](https://longbridge.com/en/news/294121514.md)
- [NeuroPace says FDA deems epilepsy label expansion filing not approvable in current form](https://longbridge.com/en/news/294110473.md)
- [Autonomix Medical Updates Cash Position and Share Count](https://longbridge.com/en/news/294091571.md)
- [Flyte Partners with LDV at The Maidstone to Elevate Luxury Travel to the Hamptons | VTAK Stock News](https://longbridge.com/en/news/294216437.md)
- [Autonomix Medical secures new US patent for autonomic nervous system assessment technology](https://longbridge.com/en/news/293607812.md)